Compounds > cyfluthrin
Page last updated: 2024-08-26

cyfluthrin and Staphylococcal Infections

cyfluthrin has been researched along with Staphylococcal Infections in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (75.00)29.6817
2010's0 (0.00)24.3611
2020's1 (25.00)2.80

Authors

AuthorsStudies
Chen, Z; Deng, X; Fang, Y; Hu, Y; Li, D; Ouyang, L; Xu, H; Yu, Z; Zhang, H; Zheng, J1
Cannons, AC; Cattani, J; Eiznhamer, DA; Luna, VA; Xu, ZQ1
Besier, S; Brade, V; Giesser, I; Hunfeld, KP; Schäfer, V; Wichelhaus, TA1
Alder, JD; Ewing, P; Flamm, RK; Hernandez, L; Jarvis, K; Ma, Z; Meulbroek, J; Mitten, MJ; Mollison, K; Nilius, AM; Nukkala, M; Oleksijew, A; Or, YS; Paige, L; Tovcimak, A1

Other Studies

4 other study(ies) available for cyfluthrin and Staphylococcal Infections

ArticleYear
The antimicrobial activity of cethromycin against Staphylococcus aureus and compared with erythromycin and telithromycin.
    BMC microbiology, 2023, 04-20, Volume: 23, Issue:1

    Topics: Anti-Bacterial Agents; Drug Resistance, Multiple, Bacterial; Erythromycin; Humans; Ketolides; Lincosamides; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Multilocus Sequence Typing; Staphylococcal Infections; Staphylococcus aureus; Streptogramin B

2023
Susceptibility of 170 isolates of the USA300 clone of MRSA to macrolides, clindamycin and the novel ketolide cethromycin.
    The Journal of antimicrobial chemotherapy, 2008, Volume: 62, Issue:3

    Topics: Anti-Bacterial Agents; Clindamycin; Community-Acquired Infections; Cross Infection; Humans; Ketolides; Macrolides; Methicillin Resistance; Staphylococcal Infections; Staphylococcus aureus

2008
Selection of ketolide resistance in Staphylococcus aureus.
    International journal of antimicrobial agents, 2003, Volume: 22, Issue:1

    Topics: Anti-Bacterial Agents; Drug Resistance, Bacterial; Erythromycin; Genes, Bacterial; Humans; In Vitro Techniques; Ketolides; Macrolides; Mutation; Selection, Genetic; Staphylococcal Infections; Staphylococcus aureus

2003
Efficacies of ABT-773, a new ketolide, against experimental bacterial infections.
    Antimicrobial agents and chemotherapy, 2001, Volume: 45, Issue:9

    Topics: Animals; Bacterial Infections; Disease Models, Animal; Drug Resistance, Microbial; Erythromycin; Female; Haemophilus Infections; Haemophilus influenzae; Ketolides; Listeriosis; Lung Diseases; Male; Mice; Rats; Rats, Sprague-Dawley; Respiratory Tract Diseases; Staphylococcal Infections; Streptococcal Infections; Streptococcus pneumoniae; Treatment Outcome

2001